Related references
Note: Only part of the references are listed.Recent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents
Agnieszka Wrobel et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Design, Synthesis, Docking and Biological Evaluation of Novel 4-hydroxy Coumarin Derivatives
N. Ramalakshmi et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future
Olga Nigro et al.
ANTI-CANCER DRUGS (2021)
2D-Quantitative structure activity relationship (QSAR) modeling, docking studies, synthesis and in-vitro evaluation of 1,3,4-thiadiazole tethered coumarin derivatives as antiproliferative agents
Ramalakshmi Natarajan et al.
JOURNAL OF SAUDI CHEMICAL SOCIETY (2021)
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer A Population-Based Cohort Study
Farzin Khosrow-Khavar et al.
CIRCULATION (2020)
Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5
William C. Wright et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents
Mohit Sanduja et al.
JOURNAL OF SAUDI CHEMICAL SOCIETY (2020)
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
Melina Arnold et al.
GUT (2020)
Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations
Sinosh Skariyachan et al.
INFECTION GENETICS AND EVOLUTION (2020)
Development of QSAR machine learning-based models to forecast the effect of substances on malignant melanoma cells
Robert Ancuceanu et al.
ONCOLOGY LETTERS (2019)
In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics
Rabia Mukhtar Rana et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling
Wei Hong et al.
SCIENTIFIC REPORTS (2015)
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
QSARINS-Chem: Insubria Datasets and New QSAR/QSPR Models for Environmental Pollutants in QSARINS
Paola Gramatica et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2014)
QSARINS: A new software for the development, analysis, and validation of QSAR MLR models
Paola Gramatica et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2013)
Role of CYP1A2 polymorphisms in breast cancer risk in women
Imene Ayari et al.
MOLECULAR MEDICINE REPORTS (2013)
Natural-product-derived fragments for fragment-based ligand discovery
Bjoern Over et al.
NATURE CHEMISTRY (2013)
A STUDY ON DIHYDROFOLATE REDUCTASE AND ITS INHIBITORS: A REVIEW
A. S. Rao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH (2013)
The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells
Zhinong Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Mechanism Inspired Development of Rationally Designed Dihydrofolate Reductase Inhibitors as Anticancer Agents
Palwinder Singh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Identification of Novel Malarial Cysteine Protease Inhibitors Using Structure-Based Virtual Screening of a Focused Cysteine Protease Inhibitor Library
Falgun Shah et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Evaluation of model predictive ability by external validation techniques
Viviana Consonni et al.
JOURNAL OF CHEMOMETRICS (2010)
Breast Cancer, Estrogen Receptor and Ligands
Zhenlin Bai et al.
ARCHIV DER PHARMAZIE (2009)
Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim
Holly Heaslet et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
Structure-Guided Development of Efficacious Antifungal Agents Targeting Candida glabrata Dihydrofolate Reductase
Jieying Liu et al.
CHEMISTRY & BIOLOGY (2008)
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials
G. Ferretti et al.
BRITISH JOURNAL OF CANCER (2006)
Dihydrofolate reductase inhibitors as antibacterial agents
S Hawser et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
Drug therapy: Effectiveness of antimalarial drugs
JK Baird
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antimalarial drug discovery: Efficacy models for compound screening
DA Fidock et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Combinatorial modification of natural products:: Synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A:: A-ring modifications
J Clough et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Combinatorial synthesis of natural products
J Nielsen
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
Natural modulators of estrogen biosynthesis and function as chemopreventive agents
KPL Bhat et al.
ARCHIVES OF PHARMACAL RESEARCH (2001)
Share Paper
